Literatur
- 1
Gurwitz J H, Gore J M, Goldberg R J. et al .
Recent age-related trends in the use of thrombolytic
therapy in patients who have had acute myocardial infarction. National
Registry of Myocardial Infarction.
Ann Intern Med.
1996;
124
283-291
- 2
Collins R.
Optimizing
thrombolytic therapy of acute myocardial infarction: age is not
a contraindication.
Circulation.
1991;
84
230
(suppl II))
- 3
Ryan T J, Antman E M, Brooks N H. et al .
1999 update: ACC/AHA Guidelines
for the Management of Patients With Acute Myocardial Infarction:
Executive Summary and Recommendations: A report of the American
College of Cardiology/American Heart Association Task Force
on Practice Guidelines (Committee on Management of Acute Myocardial
Infarction).
Circulation.
1999;
100
1016-1030
- 4
Thiemann D R, Coresh J, Schulman S P. et al .
Lack of benefit for intravenous thrombolysis
in patients with myocardial infarction who are older than 75 years.
Circulation.
2000;
101
2239-2246
- 5
Berger A K, Radford M J, Wang Y. et al .
Thrombolytic therapy in older patients.
J Am
Coll Cardiol.
2000;
36
366-374
- 6
Collaborative Group .
Indications
for fibrinolytic therapy in suspected acute myocardial infarction:
collaborative overview of early mortality and major morbidity results
from all randomised trials of more than 1000 patients. Fibrinolytic
Therapy Trialists’ (FTT).
Lancet.
1994;
343
311-322
- 7
Hillis L D, Forman S, Braunwald E.
Risk stratification
before thrombolytic therapy in patients with acute myocardial infarction.
The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators.
J
Am Coll Cardiol.
1990;
16
313-315
- 8
Zehender M, Kasper W, Kauder E. et al .
Right ventricular infarction as an independent
predictor of prognosis after acute inferior myocardial infarction.
N
Engl J Med.
1993;
328
981-988
- 9
Peterson E D, Hathaway W R, Zabel K M. et al .
Prognostic significance of precordial ST
segment depression during inferior myocardial infarction in the
thrombolytic era: results in 16,521 patients.
J Am Coll Cardiol.
1996;
28
305-312
- 10
Berger P B, Ryan T J.
Inferior myocardial infarction.
High-risk subgroups.
Circulation.
1990;
81
401-411
- 11
Schroder K, Wegscheider K, Neuhaus K L. et al .
Significance of initial ST segment changes
for thrombolytic treatment in first inferior myocardial infarction.
Heart.
1997;
77
506-511
- 12
The GUSTO investigators .
An
international randomized trial comparing four thrombolytic strategies
for acute myocardial infarction.
N Engl J Med.
1993;
329
673-682
- 13
Gibson C M, Murphy S A, Rizzo M J. et al .
Relationship between TIMI frame count and
clinical outcomes after thrombolytic administration. Thrombolysis
In Myocardial Infarction (TIMI) Study Group.
Circulation.
1999;
99
1945-1950
- 14
Single-bolus tenecteplase compared
with front-loaded alteplase in acute myocardial infarction: the
ASSENT-2 double-blind randomised trial. Assessment of the Safety
and Efficacy of a New Thrombolytic Investigators.
Lancet.
1999;
354
716-722
- 15
Mark D B, Hlatky M A, Califf R M. et al .
Cost effectiveness of thrombolytic therapy with
tissue plasminogen activator as compared with streptokinase for
acute myocardial infarction.
N Engl J Med.
1995;
332
1418-1424
- 16
A clinical trial comparing primary
coronary angioplasty with tissue plasminogen activator for acute
myocardial infarction. The Global Use of Strategies to Open Occluded
Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty
Substudy Investigators.
N Engl J Med.
1997;
336
1621-1628
- 17
Tiefenbrunn A J, Chandra N C, French W J. et al .
Clinical experience with primary percutaneous
transluminal coronary angioplasty compared with alteplase (recombinant
tissue-type plasminogen activator) in patients with acute myocardial
infarction: a report from the Second National Registry of Myocardial
Infarction (NRMI- 2).
J Am Coll Cardiol.
1998;
31
1240-1245
- 18
Berger A K, Schulman K A, Gersh B J. et al .
Primary coronary angioplasty vs thrombolysis
for the management of acute myocardial infarction in elderly patients.
JAMA.
1999;
282
341-348
Dr. Jochen Müller-Ehmsen
Klinik für Innere Medizin III, Kardiologie-Angiologie-Pneumologie, Universität
zu Köln
Joseph-Stelzmann-Str. 9
50924 Köln
Telefon: 0221/478-4474
Fax: 0221/478-6550
eMail: Muller.Ehmsen@Uni-Koeln.de
